160 Healthy International (2656) H1 2025 earnings summary

Executive summary

• H1 revenue rose 6.2% YoY to RMB290.7 million, while loss for the period narrowed to RMB19.6 million from RMB83.4 million.

• Digital platform reach included 44,800+ institutions, 904,500+ medical professionals and 56.9 million registered users as of June 30, 2025; average MAUs were 3.3 million.

Financial highlights

• Revenue was RMB290.7 million, up 6.2% YoY; gross profit was RMB64.0 million, up from RMB62.6 million.

• Loss for the period narrowed to RMB19.6 million from RMB83.4 million; adjusted net loss, excluding share-based compensation and listing expenses, was RMB5.1 million versus RMB31.0 million.

• Cost of sales increased 7.3% YoY to RMB226.6 million, faster than revenue growth, mainly reflecting product-sale cost increases and distribution pricing pressure.

Outlook and guidance

• Strategic priorities remain expanding digital healthcare and wellness solutions, growing medical resources and platform traffic, and extending into new regional markets.

• Liquidity requirements are expected to be met through operating cash generation, external borrowings, Global Offering proceeds and future capital-market fundraising.

• Global Offering proceeds are planned for medical-resource coverage and platform traffic (40%), R&D (30%), product and service diversification (10%), strategic cooperation and acquisitions (10%), and working capital (10%).